Vascular Effects of Apelin In Vivo in Man-Reference-Cited by-同舟云学术

Vascular Effects of Apelin In Vivo in Man

Published:2008-09 Issue:11 Volume:52 Page:908-913
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Japp Alan G.,Cruden Nicholas L.,Amer David A.B.,Li Vivienne K.Y.,Goudie Ewan B.,Johnston Neil R.,Sharma Sushma,Neilson Ilene,Webb David J.,Megson Ian L.,Flapan Andrew D.,Newby David E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11;O'Dowd;Gene,1993

2. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor;Tatemoto;Biochem Biophys Res Commun,1998

3. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential;Japp;Biochem Pharmacol,2008

4. Molecular and functional characteristics of APJ;Hosoya;J Biol Chem,2000

5. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells;Kleinz;Regul Pept,2005

Cited by 282 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice;Circulation Research;2024-09-13

2. Patching-Up Post-MI Hearts With Microparticle-Delivered Apelin;Circulation Research;2024-09-13

3. Exploring the mechanisms of Guizhifuling pills in the treatment of coronary spastic angina based on network pharmacology combined with molecular docking;Medicine;2024-07-19

4. Expression of the apelin receptor, a novel potential therapeutic target, and its endogenous ligands in diverse stem cell populations in human glioblastoma;Frontiers in Neuroscience;2024-05-13

5. The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan;Frontiers in Pharmacology;2024-04-09